Quality of Life of Patients With a History of Drug Allergy in Thailand
1 other identifier
observational
306
1 country
2
Brief Summary
Quality of life of patients with a history of drug allergy in Thailand will be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2012
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 12, 2012
CompletedFirst Posted
Study publicly available on registry
August 16, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedFebruary 18, 2019
February 1, 2019
5 years
August 12, 2012
February 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The quality of life of Thai patients with a history of drug allergy evaluating by DrHy-Q (Thai version)
1 year
Secondary Outcomes (1)
The correlation between DrHy-Q (Thai version) and WHOQOL-BREF-THAI
1 year
Study Arms (1)
Drug allergy patients
Patients with a history of drug allergy in Thailand
Interventions
Eligibility Criteria
Thai patients with a history of drug allergy
You may qualify if:
- Have a history of drug allergy
- At least 18 years of age
You may not qualify if:
- Not be able to understand Thai language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chulalongkorn Universitylead
- Mahidol Universitycollaborator
Study Sites (2)
Faculty of Medicine, Chulalongkorn University
Bangkok, 10330, Thailand
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Bangkok, Thailand
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jettanong Klaewsongkram, MD
Chulalongkorn University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Division of Allergy and Clinical Immunology, Department of Medicine
Study Record Dates
First Submitted
August 12, 2012
First Posted
August 16, 2012
Study Start
August 1, 2012
Primary Completion
August 1, 2017
Study Completion
October 1, 2017
Last Updated
February 18, 2019
Record last verified: 2019-02